DEFA14A ·Filed Apr 20, 2026

RDNT

RadNet, Inc.
NEUTRAL
Impact 3/10
Horizonweeks Processed5mo ago SEC0001683168-26-003087
Proxy solicitation materials
Actionable Insight • Neutral

The filing is a standard proxy statement for an annual meeting. Monitor the shareholder vote results for the equity incentive plan amendment, as approval could lead to future share dilution.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
RDNT ▲ +9.53% at T+60d
NEUTRAL call ✓ call won +9.53% · α vs SPY +2.63% · entry $57.51 → $62.99
Entry anchored
Apr 20, 03:59 PM ET
via exchange tick
T+1d
+0.56%
call +0.56% · α -0.46%
$57.83
settled 5mo ago
T+5d
+0.66%
call +0.66% · α -0.42%
$57.89
settled 5mo ago
T+20d
-5.81%
call -5.81% · α -10.72%
$54.17
settled 5mo ago
T+60d
+9.53%
call +9.53% · α +2.63%
$62.99
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

RadNet, Inc. filed its definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, outlining the board's recommendations for the election of directors, ratification of auditors, approval of executive compensation, and an amendment to its equity incentive plan.

Key Facts

  • Company: RadNet, Inc. (RDNT)
  • Filing Type: DEFA14A (Definitive Additional Materials)
  • Meeting Date: June 2, 2026
  • Proposals: 1) Election of 6 directors, 2) Ratification of Ernst & Young LLP as auditors, 3) Advisory vote on executive compensation, 4) Approval of an amendment to the Equity Incentive Plan

Financial Impact

No immediate financial impact; routine governance filing.

dilution

Risk Factors

  • Shareholder dissent on executive compensation or the equity plan amendment could lead to a negative vote, potentially impacting executive morale or retention.
  • Failure to ratify auditors could signal a significant governance issue, though this is highly unlikely.

Market Snapshot

Exchange
Nasdaq
Sector
Services-Medical Laboratories

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001683168-26-003087
Document: 0001683168-26-003087-index.html0001683168-26-003087
Document: 0001683168-26-003087.txt0001683168-26-003087
14 reports for RDNT
Performance horizon
50% Hit rate 3 of 6 directional calls best @ T+60▲ +26.65%Jun 25, 2026
Filters
Rows
Reports for RDNT — sortable, filterable
TypeNow
Aug 10, 2026
7w ago
8-K
MIXED ★ 6/10
$77.28 $71.97▼ −6.87%▼ −5.96%$69.93 (−9.51%)
Aug 9, 2026
7w ago
Press Release
MIXED ★ 6/10
$77.28 $71.97▼ −6.87%▼ −5.96%$69.93 (−9.51%)
Jun 25, 2026
14w ago
Press Release
BULLISH ★ 5/10
$60.01 $60.98▲ +1.62%▲ +1.09%$69.93 (+16.53%)
Jun 10, 2026
16w ago
8-K
NEUTRAL ★ 5/10
$58.20 $65.94▲ +13.30%▲ +11.41%$69.93 (+20.15%)
Jun 3, 2026
17w ago
8-K
NEUTRAL ★ 4/10
$51.87 $68.75▲ +32.54%▲ +33.54%$69.93 (+34.82%)
May 11, 2026
20w ago
8-K
MIXED ★ 6/10
$55.90 $56.18▲ +0.50%▲ +0.81%$69.93 (+25.10%)
May 10, 2026
20w ago
Press Release
BULLISH ★ 7/10
$55.90 $56.18▲ +0.50%▲ +0.81%$69.93 (+25.10%)
Apr 28, 2026
22w ago
Press Release
BULLISH ★ 7/10
$57.89 $53.84▼ −7.00%▼ −12.45%$69.93 (+20.80%)
Apr 20, 2026
23w ago
DEFA14A
NEUTRAL ★ 3/10
$57.51 $54.17▼ −5.81%▼ −10.72%$69.93 (+21.60%)
Mar 11, 2026
29w ago
Press Release
NEUTRAL ★ 3/10
$59.78 $55.43▼ −7.28%▼ −9.25%$69.93 (+16.98%)
Showing 10 of 14

US Market Status

Market Closed — Opens Mon (39h 27m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access